|
|
News Breaks | | | | September 17, 2012 | | 16:56 EDT |  | NVIV | Invivo Therapeutics announces chief science officer resigning
On September 11, Dr. Edward D. Wirth, III notified InVivo Therapeutics that he was resigning his position as Chief Science Officer of the Company, effective September 21. The Company’s Board of Directors has appointed Brian Hess, Director of Product Development of the Company, to serve as Interim Chief Science Officer commencing September 21. | |
|
News For NVIV From The Last 14 Days Check below for free stories on NVIV the last two weeks. |
|
|
| There are no results for NVIV |
|
|
|
|
|
|
